2026 Richard B. Gaynor: Biology and Biochemistry Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Biology and Biochemistry	78	4502	4157	2188	1972	179	24665

Overview

Richard B. Gaynor is affiliated with Eli Lilly in the United States and focuses on research in medicine, immunology, and microbiology. Their scientific contributions are primarily situated within subfields such as immunology, oncology, molecular biology, infectious diseases, and radiology, nuclear medicine, and imaging.

Their research topics include:

Immunotherapy and Immune Responses
CAR-T cell therapy research
Vaccines and immunoinformatics approaches
Cancer Immunotherapy and Biomarkers
Monoclonal and Polyclonal Antibodies Research
SARS-CoV-2 and COVID-19 Research
T-cell and B-cell Immunology

Frequent co-authors collaborating with Richard B. Gaynor include:

Asaf Poran
Michael S. Rooney
Divya Lenkala
Dewi Harjanto
Marit M. van Buuren

The scientist's works have been published in various venues, with multiple publications in:

Regular and Young Investigator Award Abstracts
Cell
Cell Reports Methods
Nature Medicine
Cancer Research

Among the recent papers authored or co-authored by Richard B. Gaynor are:

A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer, 2020, Cell
Personalized neoantigen vaccine NEO-PV-01 with chemotherapy and anti-PD-1 as first-line treatment for non-squamous non-small cell lung cancer, 2022, Cancer Cell
A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus disease, 2024, Cell
Sequence-based prediction of SARS-CoV-2 vaccine targets using a mass spectrometry-based bioinformatics predictor identifies immunogenic T cell epitopes, 2020, Genome Medicine
The T-cell-directed vaccine BNT162b4 encoding conserved non-spike antigens protects animals from severe SARS-CoV-2 infection, 2023, Cell

Best Publications

The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β

Min-Jean Yin;Yumi Yamamoto;Richard B. Gaynor

2350
Citations
Cloning and characterization of a novel cellular protein, TDP-43, that binds to human immunodeficiency virus type 1 TAR DNA sequence motifs.

S H Ou;F Wu;D Harrich;L F García-Martínez

894
Citations
IκB kinases: key regulators of the NF-κB pathway

Yumi Yamamoto;Richard B Gaynor

868
Citations
Histone H3 phosphorylation by IKK-α is critical for cytokine-induced gene expression

Yumi Yamamoto;Udit N. Verma;Shashi Prajapati;Youn-Tae Kwak

852
Citations
Sulindac Inhibits Activation of the NF-κB Pathway

Yumi Yamamoto;Min-Jean Yin;Keng-Mean Lin;Richard B. Gaynor

736
Citations
A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer.

Patrick A. Ott;Siwen Hu-Lieskovan;Bartosz Chmielowski;Ramaswamy Govindan

670
Citations
TAK1 is Critical for IκB Kinase-mediated Activation of the NF-κB Pathway

Giichi Takaesu;Rama M. Surabhi;Kyu-Jin Park;Jun Ninomiya-Tsuji

504
Citations
Cellular transcription factors involved in the regulation of HIV-1 gene expression.

Richard Gaynor

472
Citations
Small Interfering RNAs Directed against β-Catenin Inhibit the in Vitro and in Vivo Growth of Colon Cancer Cells

Udit N. Verma;Rama M. Surabhi;Aurelia Schmaltieg;Carlos Becerra

470
Citations
Interactions of cellular proteins involved in the transcriptional regulation of the human immunodeficiency virus.

Joseph A Garcia;F. K. Wu;R. Mitsuyasu;R. B. Gaynor

393
Citations
HTLV-I Tax Protein Binds to MEKK1 to Stimulate IκB Kinase Activity and NF-κB Activation

Min Jean Yin;Lori B. Christerson;Yumi Yamamoto;Youn Tae Kwak

381
Citations
Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulation.

Joseph A Garcia;D. Harrich;E. Soultanakis;F. Wu

374
Citations
Role of the TAB2‐related protein TAB3 in IL‐1 and TNF signaling

Tohru Ishitani;Giichi Takaesu;Jun Ninomiya-Tsuji;Hiroshi Shibuya

348
Citations
Identification and validation of genes involved in the pathogenesis of colorectal cancer using cDNA microarrays and RNA interference.

Noelle Sevilir Williams;Richard B. Gaynor;Shane Scoggin;Udit Verma

314
Citations
RNA interference directed against viral and cellular targets inhibits human immunodeficiency Virus Type 1 replication.

Rama M. Surabhi;Richard B. Gaynor

308
Citations
Methylation of SPT5 Regulates Its Interaction with RNA Polymerase II and Transcriptional Elongation Properties

Youn Tae Kwak;Jun Guo;Shashi Prajapati;Kyu-Jin Park

307
Citations
Absolute dependence on kappa B responsive elements for initiation and Tat-mediated amplification of HIV transcription in blood CD4 T lymphocytes.

J Alcamí;T Laín de Lera;L Folgueira;M A Pedraza

298
Citations
Domains in the SPT5 Protein That Modulate Its Transcriptional Regulatory Properties

Dmitri Ivanov;Youn Tae Kwak;Jun Guo;Richard B. Gaynor

285
Citations
Functional domains required for tat-induced transcriptional activation of the HIV-1 long terminal repeat.

Joseph A Garcia;D. Harrich;L. Pearson;R. Mitsuyasu

280
Citations
Heat Shock Protein 27 Association with the IκB Kinase Complex Regulates Tumor Necrosis Factor α-induced NF-κB Activation

Kyu-Jin Park;Richard B. Gaynor;Youn Tae Kwak

279
Citations